[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis].
D004295:Dihydroxyphenylalanine; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D010300:Parkinson Disease; D020734:Parkinsonian Disorders
D008996:Monoamine Oxidase Inhibitors; D004295:Dihydroxyphenylalanine
DOPA; MONOAMINE OXIDASE INHIBITORS; PARALYSIS AGITANS